Association between variants of 5-hydroxytryptamine receptor 3C (HTR3C) and chemotherapy-induced symptoms in women receiving adjuvant treatment for breast cancer.
Breast cancer research and treatment 2014 Feb 144 (1): 123-31.
Pud Dorit, Har-Zahav Gil, Laitman Yael, Rubinek Tami, Yeheskel Adva, Ben-Ami Sarah, Kaufman Bella, Friedman Eitan, Symon Zvi, Wolf I
Polymorphisms in the novel serotonin receptor subunit gene HTR3C show different risks for acute chemotherapy-induced vomiting after anthracycline chemotherapy.
Journal of cancer research and clinical oncology 2008 Oct 134 (10): 1079-86.
Fasching P A, Kollmannsberger B, Strissel P L, Niesler B, Engel J, Kreis H, Lux M P, Weihbrecht S, Lausen B, Bani M R, Beckmann M W, Strick